PuSH - Publikationsserver des Helmholtz Zentrums München

Zeitschriften-Browsing

11 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
Alle Publikationen dieser Seite in den Korb legen
1.
Audebrand, A.* et al.: Second-generation prokineticin PKR1 receptor agonists: Advancing cardioprotection against chemotherapy-induced toxicity. Br. J. Pharmacol. 183, 3377-3394 (2026)
2.
Jia, J. ; Liu, R.* ; Adamide, T.A.* ; Fernandez, I.E. & Stathopoulos, G.T.*: Targeting KRAS for cancer therapy. Br. J. Pharmacol., DOI: 10.1111/bph.70546 (2026)
3.
Rajeeth, K.* et al.: Pharmacological activation of NO-cGMP signalling attenuates metabolic dysfunction-associated steatohepatitis. Br. J. Pharmacol., DOI: 10.1111/bph.70523 (2026)
4.
Krier, J. et al.: PDE4D and PDE3B orchestrate distinct cAMP microdomains in 3T3-L1 adipocytes. Br. J. Pharmacol., DOI: 10.1111/bph.70216 (2025)
5.
Lynderup, E.M.* et al.: Methanobactin rapidly facilitates biliary copper excretion in a Wilson disease rat model visualised by 64Cu PET/MRI. Br. J. Pharmacol., DOI: 10.1111/bph.70099 (2025)
6.
Kogut-Günthel, M.M.* et al.: The path to the G protein-coupled receptor structural landscape: Major milestones and future directions. Br. J. Pharmacol., DOI: 10.1111/bph.17314 (2024)
7.
Benkner, A.* et al.: Riociguat attenuates left ventricular proteome and microRNA profile changes after experimental aortic stenosis in mice. Br. J. Pharmacol. 179, 4575-4592 (2022)
8.
Costa, R. et al.: A drug screen with approved compounds identifies amlexanox as a novel Wnt/β-catenin activator inducing lung epithelial organoid formation. Br. J. Pharmacol. 178, 4026-4041 (2021)
9.
Sander, P.* et al.: Approved drugs ezetimibe and disulfiram enhance mitochondrial Ca2+ uptake and suppress cardiac arrhythmogenesis. Br. J. Pharmacol., DOI: 10.1111/bph.15630 (2021)
10.
Rüdebusch, J.* et al.: Stimulation of soluble guanylyl cyclase (sGC) by riociguat attenuates heart failure and pathological cardiac remodelling. Br. J. Pharmacol., DOI: 10.1111/bph.15333 (2020)
11.
Ehrhardt, H. et al.: Enhanced anti-tumour effects of vinca alkaloids given separately from cytostatic therapies. Br. J. Pharmacol. 168, 1558-1569 (2013)